(Reuters) -Merck Animal Health, a unit of Merck, said on Thursday it would invest $895 million to expand its manufacturing facility in De Soto, Kansas.

The capital expansion includes an investment of $860 million in the site's existing manufacturing facility and a further $35 million in its research and development laboratories, Merck Animal Health said.

Commercial manufacturing is expected to begin in 2030, the company added, and would create more than 200 full-time roles.

Merck Animal Health is partnering with the state of Kansas on expansion of the existing manufacturing facility.

Other drugmakers such as Eli Lilly, Johnson & Johnson and Gilead have recently announced additional investments to boost domestic production amid U.S. President Donald Trump's tariff policies.